InvestorsHub Logo
Followers 260
Posts 4976
Boards Moderated 0
Alias Born 07/22/2013

Re: murocman post# 95

Thursday, 04/29/2021 2:57:51 PM

Thursday, April 29, 2021 2:57:51 PM

Post# of 159
Two drugs in phase II / III.

One of them (sepofarsen) already has papers published on the positive effect at 15 months. Confirmation of positive sepofarsen data will send this to $10+ near term imo.

My target by 2022 is $18/share.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PRQR News